Return On Assets of Amylyx Pharmaceuticals, Inc. from 30 Sep 2022 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Amylyx Pharmaceuticals, Inc. quarterly and annual Return On Assets in % history and change rate from 30 Sep 2022 to 30 Sep 2025.
  • Amylyx Pharmaceuticals, Inc. Return On Assets for the quarter ending 30 Sep 2025 was -62%, a 10% increase year-over-year.
  • Amylyx Pharmaceuticals, Inc. annual Return On Assets for 2024 was -101%, a 1047% decline from 2023.
  • Amylyx Pharmaceuticals, Inc. annual Return On Assets for 2023 was 11%.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Amylyx Pharmaceuticals, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -62% +7% +10% 01 Jul 2025 30 Sep 2025
Q2 2025 -87% -49% -128% 01 Apr 2025 30 Jun 2025
Q1 2025 -88% -73% -473% 01 Jan 2025 31 Mar 2025
Q4 2024 -101% -112% -1047% 01 Oct 2024 31 Dec 2024
Q3 2024 -68% -69% -16112% 01 Jul 2024 30 Sep 2024
Q2 2024 -38% -18% -89% 01 Apr 2024 30 Jun 2024
Q1 2024 -15% +34% +69% 01 Jan 2024 31 Mar 2024
Q4 2023 11% +85% 01 Oct 2023 31 Dec 2023
Q3 2023 0% +94% 01 Jul 2023 30 Sep 2023
Q2 2023 -20% 01 Apr 2023 30 Jun 2023
Q1 2023 -49% 01 Jan 2023 31 Mar 2023
Q4 2022 -74% 01 Oct 2022 31 Dec 2022
Q3 2022 -94% 01 Jul 2022 30 Sep 2022

Amylyx Pharmaceuticals, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -101% -112% -1047% 01 Jan 2024 31 Dec 2024
2023 11% +85% 01 Jan 2023 31 Dec 2023
2022 -74% 01 Jan 2022 31 Dec 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.